<div id="readability-page-1"><p>Stifel Nicolaus analyst Justin Keywood downgraded Quipt Home Medical to a Sell yesterday and set a price target of C$5.10. The company’s shares closed yesterday at C$4.65.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>According to TipRanks, Keywood is an analyst with an average return of <span>-5.3%</span> and a 43.91% success rate. Keywood covers the Healthcare sector, focusing on stocks such as WELL Health Technologies Corp, Vitalhub, and HEALWELL AI.</p> <p>Quipt Home Medical has an analyst consensus of Hold, with a price target consensus of C$5.31.</p></div>

QIPT

<p>Stifel Nicolaus analyst Justin Keywood downgraded Quipt Home Medical to a Sell, setting a price target of C$5.10. The shares closed at C$4.65. Keywood has an average return of -5.3% and a 43.91% success rate. The analyst consensus for Quipt Home Medical is Hold, with a price target of C$5.31.</p>

Stifel Nicolaus downgrades Quipt Home Medical (QIPT) to a Sell